Matthew Clarence Breeggemann, M.D.

85% fewer Medicare Part D claims than the average nephrology physician in 2024

216 Medicare Part D claims for 77 beneficiaries, against an average of 1,465 among the 10,986 providers of this specialty who prescribed in Part D. Brand-name drugs were 14% of claims.

Most prescribed

1. Chlorthalidone28 claims
2. Losartan Potassium28 claims
3. Potassium Citrate Er20 claims
4. Lisinopril18 claims
5. Farxiga15 claims
6. Furosemide14 claims

Source: CMS Medicare Part D Prescribers by Provider and Drug, 2024 (data.cms.gov). Part D covers prescriptions for Medicare patients only; drugs with fewer than 11 claims are not published.

The practice group's MIPS final score for 2023 (Medicare payment program): 91.9 of 100

The Merit-based Incentive Payment System score is reported for the practice group, not for one clinician alone. Four categories are weighted into the final score; the average among 454,083 clinicians with a measured score was 83.5.

Source: CMS Quality Payment Program, MIPS performance year 2023, group reporting; category weights for 2023 (qpp.cms.gov).

Industry payments in 2024: $9,364.43

15 payments; by number, the most common kind was food and beverage; the largest payer was Novo Nordisk AS. The 8,230 providers of this specialty with any payment received $3,091.37 on average. Payments are reported by manufacturers, not by the provider, and are not a sign of wrongdoing.

Source: CMS Open Payments, program year 2024 (openpaymentsdata.cms.gov); average among providers of this specialty with at least one payment.

Bills Medicare through 3 group practices

1. Regents OF The University OF CaliforniaSan Francisco, CA
2. Ucsf Medical Group Business ServicesSan Francisco, CA
3. University OF California San FranciscoSan Francisco, CA

Source: CMS Doctors and Clinicians National Downloadable File (the group practices a clinician bills Medicare through) (data.cms.gov).